Synergy Names Chief Strategy Officer
This article was originally published in Scrip
Synergy Pharmaceuticals Inc. has appointed Marino Garcia to the newly created role of executive vice president and chief strategy officer – effective immediately. Garcia has been senior vice president corporate development and part of the leadership team since he joined Synergy in 2014. Previously he was vice president of global business development at Aptalis Pharma (acquired by Forest Labs) and vice president of US commercial operations and new product development at Aspreva Pharmaceuticals (acquired by Vifor Pharmaceuticals). Earlier in his career, Garcia held various US and international leadership roles in companies like Eli Lilly & Co and Pfizer.